Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Khuri, FR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Moore, RJ; Doherty, DA; Do, KA; Chamberlain, RM; Khuri, FR
      Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx

      ETHNICITY & HEALTH
    2. Shin, DM; Donato, NJ; Perez-Soler, R; Shin, HJC; Wu, JY; Zhang, P; Lawhorn, K; Khuri, FR; Glisson, BS; Myers, J; Clayman, G; Pfister, D; Falcey, J; Waksal, H; Mendelsohn, J; Hong, WK
      Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer

      CLINICAL CANCER RESEARCH
    3. Khuri, FR; Wu, H; Lee, JJ; Kemp, BL; Lotan, R; Lippman, SM; Feng, L; Hong, WK; Xu, XC
      Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    4. Khuri, FR; Kim, ES; Lee, JJ; Winn, RJ; Benner, SE; Lippman, SM; Fu, KK; Cooper, JS; Vokes, EE; Chamberlain, RM; Williams, B; Pajak, TF; Goepfert, H; Hong, WK
      The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    5. Khuri, FR; Lee, JS; Lippman, SM; Lee, JJ; Kalapurakal, S; Yu, R; Ro, JY; Morice, RC; Hong, WK; Hittelman, WN
      Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    6. Kim, ES; Khuri, FR; Herbst, RS
      Epidermal growth factor receptor biology (IMC-C225)

      CURRENT OPINION IN ONCOLOGY
    7. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    8. Pisters, KMW; Newman, RA; Coldman, B; Shin, DM; Khuri, FR; Hong, WK; Glisson, BS; Lee, JS
      Phase I trial of oral green tea extract in adult patients with solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    9. Shin, DM; Khuri, FR; Murphy, B; Garden, AS; Clayman, G; Francisco, M; Liu, D; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, V; Myers, J; Morrison, W; Gillenwater, A; Ang, KK; Lippman, SM; Goepfert, H; Hong, WK
      Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial

      JOURNAL OF CLINICAL ONCOLOGY
    10. Khuri, FR; Rigas, JR; Figlin, RA; Gralla, RJ; Shin, DM; Munden, R; Fox, N; Huyghe, MR; Kean, Y; Reich, SD; Hong, WK
      Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    11. Tseng, JE; Glisson, BS; Khuri, FR; Shin, DM; Myers, JN; El-Naggar, AK; Roach, JS; Ginsberg, LE; Thall, PF; Wang, XM; Teddy, S; Lawhorn, KN; Zentgraf, RE; Steinhaus, GD; Pluda, JM; Abbruzzese, JL; Hong, WK; Herbst, RS
      Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

      CANCER
    12. Shin, DM; Khuri, FR; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, VM; Clayman, G; Lee, JJ; Ang, KK; Lippman, SM; Hong, WK
      Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma

      CANCER
    13. Lippman, SM; Lee, JJ; Karp, DD; Vokes, EE; Benner, SE; Goodman, GE; Khuri, FR; Marks, R; Winn, RJ; Fry, W; Graziano, SL; Gandara, DR; Okawara, G; Woodhouse, CL; Williams, B; Perez, C; Kim, HW; Lotan, R; Roth, JA; Hong, WK
      Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    14. Lee, JJ; Liu, D; Lee, JS; Kurie, JM; Khuri, FR; Ibarguen, H; Morice, RC; Walsh, G; Ro, JY; Broxson, A; Hong, WK; Hittelman, WN
      Long-term impact of smoking on lung epithelial proliferation in current and former smokers

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    15. Khuri, FR; Lippman, SH
      Lung cancer chemoprevention

      SEMINARS IN SURGICAL ONCOLOGY
    16. Khuri, FR; Nemunaitis, J; Ganly, I; Arseneau, J; Tannock, IF; Romel, L; Gore, M; Ironside, J; MacDougall, RH; Heise, C; Randlev, B; Gillenwater, AM; Bruso, P; Kaye, SB; Hong, WK; Kirn, DH
      A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

      NATURE MEDICINE
    17. Kurie, JM; Lee, JS; Khuri, FR; Mao, L; Morice, RC; Lee, JJ; Walsh, GL; Broxson, A; Lippman, SM; Ro, JY; Kemp, BL; Liu, D; Fritsche, HA; Xu, XC; Lotan, R; Hong, WK
      N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium

      CLINICAL CANCER RESEARCH
    18. Khuri, FR; Kurie, JM
      Antisense approaches enter the clinic

      CLINICAL CANCER RESEARCH
    19. Herbst, RS; Yano, S; Kuniyasu, H; Khuri, FR; Bucana, CD; Guo, F; Liu, D; Kemp, B; Lee, JJ; Hong, WK; Fidler, IJ
      Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma

      CLINICAL CANCER RESEARCH
    20. Zhou, X; Kemp, BL; Khuri, FR; Liu, D; Lee, JJ; Wu, WG; Hong, WK; Mao, L
      Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    21. Yen, N; Ioannides, CG; Xu, K; Swisher, SG; Lawrence, DD; Kemp, BL; El-Naggar, AK; Cristiano, RJ; Fang, BL; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Merritt, JA; Mukhopadhyay, T; Nesbitt, JC; Nguyen, D; Perez-Soler, R; Pisters, KMW; Putnam, JB; Schrump, DS; Shin, DM; Walsh, GL; Roth, JA
      Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)

      CANCER GENE THERAPY
    22. Nemunaitis, J; Swisher, SG; Timmons, T; Connors, D; Mack, M; Doerksen, L; Weill, D; Wait, J; Lawrence, DD; Kemp, BL; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Shin, DM; Walsh, GL; Merritt, J; Roth, J
      Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    23. Khuri, FR; Lotan, R; Kemp, BL; Lippman, SM; Wu, H; Feng, L; Lee, JJ; Cooksley, CS; Parr, B; Chang, E; Walsh, GL; Lee, JS; Hong, WK; Xu, XC
      Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    24. Khuri, FR; Shin, DM; Glisson, BS; Lippman, SM; Hong, WK
      Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions

      SEMINARS IN ONCOLOGY
    25. Soria, JC; Jang, SJ; Khuri, FR; Hassan, K; Lin, D; Hong, WK; Mao, L
      Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication

      CANCER RESEARCH
    26. Liu, NS; Spitz, MR; Kemp, BL; Cooksley, C; Fossella, FV; Lee, JS; Hong, WK; Khuri, FR
      Adenocarcinoma of the lung in young patients - The M. D. Anderson experience

      CANCER
    27. Tang, XM; Khuri, FR; Lee, JJ; Kemp, BL; Liu, D; Hong, WK; Mao, L
      Hypermethylation of the death-associated protein (DAP) kinase promoter andaggressiveness in stage I non-small-cell lung cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    28. Izzo, JG; Khuri, FR; Hong, WK
      Adjuvant biological therapy of head and neck cancer

      STRATEGIES IN ADJUVANT THERAPY
    29. Khuri, FR; Tannous-Khuri, LR; Hong, WK
      Chemoprevention of lung cancer

      MULTIMODALITY TREATMENT OF LUNG CANCER
    30. Garden, AS; Glisson, BS; Ang, KK; Morrison, WH; Lippman, SM; Byers, RM; Geara, F; Clayman, GL; Shin, DM; Callender, DL; Khuri, FR; Goepfert, H; Hong, WK; Peters, LJ
      Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses

      JOURNAL OF CLINICAL ONCOLOGY
    31. Tseng, JE; Kemp, BL; Khuri, FR; Kurie, JH; Lee, JS; Zhou, X; Liu, D; Hong, WK; Mao, L
      Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers

      CANCER RESEARCH
    32. Swisher, SG; Roth, JA; Nemunaitis, J; Lawrence, DD; Kemp, BL; Carrasco, CH; Connors, DG; El-Naggar, AK; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Mack, M; Merritt, JA; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Savin, M; Schrump, DS; Shin, DM; Shulkin, A; Walsh, GL; Wait, J; Weill, D; Waugh, MKA
      Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    33. KHURI FR; FOSSELLA FV; LEE JS; MURPHY WK; SHIN DM; MARKOWITZ AB; GLISSON BS
      PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/

      Journal of interferon & cytokine research
    34. SHIN DM; WALSH GL; SWISHER S; WIMBERLY A; SHIN HJC; RO JY; KHURI FR; LEE JS; HONG WK; KHOKHAR AR; PEREZSOLER R
      ANTITUMOR-ACTIVITY OF A LIPOSOME-ENTRAPPED CISPLATIN ANALOG (L-NDDP) ADMINISTERED INTRAPLEURALLY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)

      Annals of oncology
    35. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; PEREZSOLER R; KHURI FR; DELCLOS ME; FOSSELLA FV
      THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/

      Annals of oncology
    36. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; PAPADIMITRAKOPOULOU V; LEE JJ; LAWHORN K; GILLENWATER AM; ANG KK; CLAYMAN GL; CALLENDER DL; HONG WK; LIPPMAN SM
      PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Journal of clinical oncology
    37. SHIN DM; GLISSON BS; KHURI FR; HONG WK; LIPPMAN SM
      ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Seminars in oncology
    38. ROTH JA; SWISHER SG; LAWRENCE DD; KEMP BL; CARRASCO CH; ELNAGGAR AK; FOSSELA FV; GLISSON BS; HONG WK; KHURI FR; KURIE JM; NESBITT JC; PISTERS K; PUTNAM JB; SCHRUMP DS; SHIN DM; WALSH GL
      LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER

      British Journal of Cancer
    39. KURIE JM; LEE JS; MORICE RC; WALSH GL; KHURI FR; BROXSON A; RO JY; FRANKLIN WA; YU R; HONG WK
      AUTOFLUORESCENCE BRONCHOSCOPY IN THE DETECTION OF SQUAMOUS METAPLASIAAND DYSPLASIA IN CURRENT AND FORMER SMOKERS

      Journal of the National Cancer Institute
    40. SPITZ MR; MCPHERSON RS; JIANG H; HSU TC; TRIZNA Z; LEE JJ; LIPPMAN SM; KHURI FR; STEFFENBATEY L; CHAMBERLAIN RM; SCHANTZ SP; HONG WK
      CORRELATES OF MUTAGEN SENSITIVITY IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CANCER

      Cancer epidemiology, biomarkers & prevention
    41. KHURI FR; KURIE JM; HONG WK
      CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER

      Hematology/oncology clinics of North America
    42. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; LAWHORN K; HONG WK; LIPPMAN SM
      RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Seminars in oncology
    43. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; KHURI FR; SCHEA R; FOSSELLA FV
      PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/

      Seminars in oncology
    44. KHURI FR; LIPPMAN SM; SPITZ MR; LOTAN R; HONG WK
      MOLECULAR EPIDEMIOLOGY AND RETINOID CHEMOPREVENTION OF HEAD AND NECK-CANCER

      Journal of the National Cancer Institute
    45. MAO L; LEE JS; KURIE JM; FAN YH; LIPPMAN SM; LEE JJ; RO JY; BROXSON A; YU R; MORICE RC; KEMP BL; KHURI FR; WALSH GL; HITTELMAN WN; HONG WK
      CLONAL GENETIC ALTERATIONS IN THE LUNGS OF CURRENT AND FORMER SMOKERS

      Journal of the National Cancer Institute
    46. KHURI FR; HONG WK; LEE JS
      NEW DIRECTIONS IN LUNG-CANCER - CHEMOPREVENTION

      Seminars in respiratory and critical care medicine
    47. KHURI FR; CHO YH; TALMAGE DA
      RETINOIC ACID-INDUCED TRANSITION FROM PROTEIN-KINASE C-BETA TO PROTEIN-KINASE C-ALPHA IN DIFFERENTIATED F9 CELLS - CORRELATION WITH ALTEREDREGULATION OF PROTOONCOGENE EXPRESSION BY PHORBOL ESTERS

      Cell growth & differentiation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 15:49:11